| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akari Therapeutics Plc | CEO, Director | Pre-Funded Warrants to purchase ADRs | 773,323 | $312,499 | $0.4041 | 16 Dec 2025 | Direct |
| Akari Therapeutics Plc | CEO, Director | American Depositary Shares representing Ordinary Shares | 298,574 | $268,716 | $0.9000 | 25 Aug 2025 | Direct |
| Akari Therapeutics Plc | CEO, Director | Series A Warrants (Right to Buy) | 133,928 | $149,999 | $1.12 | 06 Mar 2025 | Direct |
| Akari Therapeutics Plc | CEO, Director | Series B Warrants (Right to Buy) | 133,928 | $149,999 | $1.12 | 06 Mar 2025 | Direct |
| Akari Therapeutics Plc | CEO, Director | American Depository Shares representing Ordinary Shares | 47,500 | $57,950 | $1.22 | 10 Jan 2025 | Direct |
| Akari Therapeutics Plc | CEO, Director | Ordinary Shares, par value $0.0001 per share | 71,720,000 | $43,032 | $0.000600 | 03 Jan 2025 | Direct |
| Akari Therapeutics Plc | CEO, Director | Warrants to purchase ADRs | 773,323 | 16 Dec 2025 | Direct | ||
| Akari Therapeutics Plc | CEO, Director | Stock Option (Right to Buy) | 600,000 | 20 Mar 2025 | Direct | ||
| Akari Therapeutics Plc | CEO, Director | Warrants to purchase American Depositary Shares ("ADRs") | 309,328 | 16 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKTX | Akari Therapeutics Plc | 16 Dec 2025 | 4 | +$437,499 | 4 | CEO, Director | 18 Dec 2025, 21:56 |
| AKTX | Akari Therapeutics Plc | 21 Aug 2025 | 3 | +$19,540 | 4 | CEO, Director | 29 Aug 2025, 16:55 |
| AKTX | Akari Therapeutics Plc | 23 Jun 2025 | 2 | +$7,120 | 4 | President & CEO, Director | 25 Jun 2025, 16:30 |
| AKTX | Akari Therapeutics Plc | 20 Jun 2025 | 1 | +$12,000 | 4 | President & CEO, Director | 24 Jun 2025, 16:30 |
| AKTX | Akari Therapeutics Plc | 17 Jun 2025 | 1 | +$18,000 | 4 | President & CEO, Director | 20 Jun 2025, 16:05 |
| AKTX | Akari Therapeutics Plc | 12 Jun 2025 | 2 | +$54,350 | 4 | CEO, Director | 16 Jun 2025, 17:00 |
| AKTX | Akari Therapeutics Plc | 10 Jun 2025 | 1 | +$25,400 | 4 | CEO, Director | 12 Jun 2025, 16:30 |
| AKTX | Akari Therapeutics Plc | 20 Mar 2025 | 2 | $0 | 4 | Director | 24 Mar 2025, 17:00 |
| AKTX | Akari Therapeutics Plc | 06 Mar 2025 | 3 | +$449,998 | 4 | Director | 10 Mar 2025, 17:00 |
| AKTX | Akari Therapeutics Plc | 10 Jan 2025 | 1 | +$14,201 | 4/A | Director | 07 Feb 2025, 16:30 |
| AKTX | Akari Therapeutics Plc | 03 Jan 2025 | 1 | +$1,032 | 4 | Director | 07 Jan 2025, 16:30 |
| AKTX | Akari Therapeutics Plc | 27 Dec 2024 | 1 | +$20,000 | 4 | Director | 30 Dec 2024, 16:30 |
| AKTX | Akari Therapeutics Plc | 26 Dec 2024 | 1 | +$15,000 | 4 | Director | 27 Dec 2024, 16:30 |
| AKTX | Akari Therapeutics Plc | 16 Dec 2024 | 0 | $0 | 3 | Director | 26 Dec 2024, 16:30 |